Human umbilical cord-derived mesenchymal stem cells utilise activin-A to suppress interferon-gamma production by natural killer cells

Frontiers in Immunology

Volumn 5, Issue DEC, 2014, Pages

  Chatterjee, Debanjana ^a   Marquardt, Nicole ^a   Tufa, Dejene Milkessa ^a   Hatlapatka, Tim ^b   Hass, Ralf ^a   Kasper, Cornelia ^b,c   von Kaisenberg, Constantin ^a   Schmidt, Reinhold Ernst ^a   Jacobs, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Activin A; IFN production; NK cell; Suppression; T bet; UC MSC

Indexed keywords

5' NUCLEOTIDASE; ACTIVIN A; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 12; INTERLEUKIN 18; PROSTAGLANDIN E2; STAT4 PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR T BET;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHONDROGENESIS; DNA BINDING; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INFANT; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL;

EID: 84919479512     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00662     Document Type: Article

References (28)

1. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon- gamma: an overview of signals, mechanisms and functions. J Leukoc Biol (2004) 75: doi:10.1189/jlb.0603252.Journal
2. Lu Y, Waller EK. Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant. Biol Blood Marrow Transplant (2010) 15:1347-1353. doi:10.1016/j.bbmt.2009.07.015.Dichotomous
3. Jacobs R, Stoll M, Stratmann G, Leo R, Link H, Schmidt RE. CD16- CD56+ natural killer cells after bone marrow transplantation. Blood (1992) 79:3239-44. Available at: http://www.ncbi.nlm.nih.gov/pubmed/1375847
4. Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest (1998) 101:1835-42. doi:10.1172/JCI1268
5. Wu K-H, Chan C-K, Tsai C, Chang Y-H, Sieber M, Chiu T-H, Ho M, Peng C-T, Wu H-P, Huang J-L. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation (2011) 91:1412-6. doi:10.1097/TP.0b013e31821aba18
6. Djouad F, Jackson WM, Bobick BE, Janjanin S, Song Y, Huang GTJ, Tuan RS. Activin A expression regulates multipotency of mesenchymal progenitor cells. Stem Cell Res Ther (2010) 1:11. doi:10.1186/scrt11
7. Robson NC, Wei H, Mcalpine T, Kirkpatrick N, Cebon J, Maraskovsky E. Activin-A attenuates several human natural killer cell functions. Blood (2009) 113:3218-3225. doi:10.1182/blood-2008-07-166926.
8. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood (2008) 111:1327-33. doi:10.1182/blood-2007-02-074997
9. Sotiropoulou P a, Perez S a, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells (2006) 24:74-85. doi:10.1634/stemcells.2004-0359
10. Giuliani M, Oudrhiri N, Noman ZM, Vernochet A, Chouaib S, Azzarone B, Durrbach A, Bennaceur-Griscelli A. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood (2011) 118:3254-62. doi:10.1182/blood-2010-12-325324
11. Bassi ÊJ, de Almeida DC, Moraes-Vieira PMM, Câmara NOS. Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Rev (2012) 8:329-42. doi:10.1007/s12015-011-9311-1
12. Noone C, Kihm A, English K, O'Dea S, Mahon BP. IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro. Stem Cells Dev (2013) 22:3003-14. doi:10.1089/scd.2013.0028
13. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (2011) 9:12. doi:10.1186/1478-811X-9-12
14. Hatlapatka T, Moretti P, Lavrentieva A, Hass R, Marquardt N, Jacobs R, Kasper C. Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng Part C Methods (2011) 17:485-93. doi:10.1089/ten.TEC.2010.0406
15. Chatterjee D, Marquardt N, Tufa D, Beauclair G, Low H, Hatlapatka T, Hass R, Kasper C, von Kaisenberg C, Schmidt R, et al. Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity. Cell Commun Signal (2014) 12:63. doi:10.1186/s12964-014-0063-9
16. Majore I, Moretti P, Stahl F, Hass R, Kasper C. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev (2011) 7:17-31. doi:10.1007/s12015-010-9165-y
17. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 8:315-7. doi:10.1080/14653240600855905
18. Matikainen S, Paananen A, Miettinen M, Kurimoto M, Julkunen I, Sareneva T. IFN alpha and IL-18 synergistically enhance IFN- q production in human NK cells: differential regulation of Stat4 activation and IFN- q gene expression by IFN- > and IL- Eur J Immunol (2001) 31:2236-2245.
19. Cho SS, Bacon CM, Sudarshan C, Robert CR, Pine R, Shea JJO. Activation of STAT4 by IL-12 and IFN-a Evidence for the Involvement of Ligand-Induced Tyrosine and Serine Phosphorylation. J Immunol (1996) 157:4781-4789.
20. Kojima H, Aizawa Y, Yanai Y, Takeuchi M, Ohta T, Ikeda M, Kurimoto M, Alerts E. An Essential Role for NF- κ B in IL-18-Induced IFN- γ Expression in KG-1 Cells. (2014)
21. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 100:655-69. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10761931
22. Sidis Y, Schneyer a L, Sluss PM, Johnson LN, Keutmann HT. Follistatin: essential role for the N-terminal domain in activin binding and neutralization. J Biol Chem (2001) 276:17718-26. doi:10.1074/jbc.M100736200
23. Kim E-J, Kim N, Cho S-G. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp Mol Med (2013) 45:e2. doi:10.1038/emm.2013.2
24. Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase mediated tryptophan degradation. Blood (2004) 103:4619-21. doi:10.1182/blood-2003-11-3909
25. Shilling HG, Guethlein L a, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol (2002) 168:2307-15. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11859120
26. Dalous J, Larghero J, Baud O. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatr Res (2012) 71:482-90. doi:10.1038/pr.2011.67
27. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (2011) 9:12. doi:10.1186/1478-811X-9-12
28. Raynaud CM, Yacoub MH. Clinical trials of bone marrow derived cells for ischemic heart failure. Time to move on? TIME, SWISS-AMI, CELLWAVE, POSEIDON and C-CURE. Glob Cardiol Sci Pract (2013) 2013:207-11. doi:10.5339/gcsp.2013.28